To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes.
Summary
What This Bill Does
This bill creates a defense biotechnology management structure. Within 90 days, the Secretary of Defense must designate a senior official with relevant biotechnology experience from an existing DOD position to serve as the senior official for biotechnology issues, head the Biotechnology Management Office, and carry out office responsibilities. Within 120 days, DOD must charter and establish the office under the Deputy Secretary of Defense to foster development, acquisition, and sustainment of broad-based biotechnology capabilities. The office must maintain a long-term research, development, acquisition, and sustainment roadmap; update acquisition and adoption policies; coordinate with DOD, the federal government, industry, academia, and international partners; propose regulatory or acquisition streamlining options; conduct competition analyses, net assessments, or forecasting; support public-private partnerships and regional innovation ecosystems; identify workforce and training gaps; and brief defense committees within 30 days after the senior official designation. The office terminates September 30, 2030. A second section amends FY2023 NDAA bioindustrial manufacturing authority to allow DOD RDT and E funds to support research, development, test, evaluation, design, and construction activities for bioindustrial manufacturing processes.
Who Benefits and How
DOD biotechnology programs benefit from a senior official, dedicated office, roadmap, and acquisition policy coordination. Bioindustrial manufacturing companies benefit if DOD research and development funds can support design and construction activities. Universities and research institutions benefit from public-private partnerships and regional biotechnology innovation ecosystems. Defense planners benefit from global competition analysis, net assessment, and forecasting. DOD workforce programs benefit from identification of biotechnology training gaps.
Who Bears the Burden and How
The Secretary of Defense and Deputy Secretary must designate, charter, and oversee the office on short deadlines. The Biotechnology Management Office must coordinate across DOD, federal agencies, industry, academia, and international partners while updating policy and roadmaps. DOD acquisition and regulatory staff may need to streamline processes for biotechnology products. Federal taxpayers fund RDT and E support for bioindustrial manufacturing process work. The office must manage a sunset date of September 30, 2030.
Key Provisions
- Requires DOD to designate a senior biotechnology official within 90 days.
- Requires DOD to establish a Biotechnology Management Office within 120 days under the Deputy Secretary of Defense.
- Requires the office to maintain a long-term roadmap, update policies, coordinate partners, analyze competition, and identify workforce gaps.
- Requires a briefing to congressional defense committees within 30 days after senior official designation.
- Authorizes DOD RDT and E funds for bioindustrial manufacturing process activities, including design and construction.
- Sunsets the Biotechnology Management Office on September 30, 2030.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Requires DOD within 90 days to designate a senior biotechnology official and within 120 days to establish a Biotechnology Management Office, then authorizes RDT and E funds for bioindustrial manufacturing process activities including design and construction.
Key Policy Areas
Defense, Biotechnology, Manufacturing, Research and Development
Primary Purpose
Requires DOD within 90 days to designate a senior biotechnology official and within 120 days to establish a Biotechnology Management Office, then authorizes RDT and E funds for bioindustrial manufacturing process activities including design and construction.
Policy Domains
Substantive provisions
Identified Gains
- DOD biotechnology programs
- Bioindustrial manufacturing companies
- Universities
- Research institutions
- Defense planners
- DOD workforce programs
Identified Costs
- Secretary of Defense
- Deputy Secretary of Defense
- Biotechnology Management Office staff
- DOD acquisition staff
- Federal taxpayers
Sponsors
Legislative Progress
In CommitteeReferred to the House Committee on Armed Services.
Introduced in House
Mr. Neguse introduced the following bill; which was referred to …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Defense officials responsible for establishing and operating the Biotechnology Management Office
Bioindustrial manufacturing research and development efforts that may receive Defense funding support
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "DOD"
- → Department of Defense
- "RDT and E"
- → Research, development, test, and evaluation
Key Definitions
Terms defined in this bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology